Keywords: اینترفرون بتا; MS; multiple sclerosis; MS-RR; relapsing-remitting multiple sclerosis; MS-SP; secondary progressive multiple sclerosis; MS-PP; primary progressive multiple sclerosis; IFN-Ã; interferon-beta; GA; glatiramer acetate; DMT; disease-modifying treatment; CIS;
مقالات ISI اینترفرون بتا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترفرون بتا; CHI3L1; chitinase 3-like 1; MS; multiple sclerosis; RRMS; relapsing-remitting multiple sclerosis; CIS; clinically isolated syndrome; DMT; disease modifying therapies; IFNβ; interferon-beta; GA; glatiramer acetate; Chitinase 3-like 1; Interferon-beta; Gla
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon-beta; Biomarkers; Treatment response; Gene expression;
Keywords: اینترفرون بتا; Disability progression; Long-term; Interferon-beta; Observational studies; Meta-analysis; Treatment effect
Keywords: اینترفرون بتا; Multiple sclerosis; Autoimmune disease; Disease modifying therapy; Thyroid disease; Interferon-Beta;
Keywords: اینترفرون بتا; Multiple sclerosis; EAE; Immunomodulation; Neuroprotection; Interferon-beta; Dimethyl fumarate; Combination therapy
The influence of interferon-β supplemented human dendritic cells on BCG immunogenicity
Keywords: اینترفرون بتا; Tuberculosis; Bacillus Calmette-Guérin; Interferon-beta; Dendritic cells; Cytokines;
Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia
Keywords: اینترفرون بتا; COPD; Chronic obstructive pulmonary disease; extensor digitorum longus; EDL; fl; fiber lengths; gastrocnemius; Gastroc; IFN-β; interferon-beta; mTORC1; mechanistic target of rapamycin complex 1; mN; milliNewton; MuRF-1; Muscle ring finger-1; MyHC; Myosin
Down-regulation of TYK2, CBLB and LMP7 genes expression in relapsing-remitting multiple sclerosis patients treated with interferon-beta
Keywords: اینترفرون بتا; Multiple sclerosis; TYK2; CBLB; LMP7; Gene; Interferon-beta;
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Theiler's murine encephalomyocarditis virus-induced demyelinating disease; Interferon-beta; Pegylated interferon-beta; Disability progression;
Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity
Keywords: اینترفرون بتا; Multiple sclerosis; Genetic burden; Weighted genetic risk score; Disease activity; Interferon-beta; Genetic risk;
Interferon-β promotes macrophage foam cell formation by altering both cholesterol influx and efflux mechanisms
Keywords: اینترفرون بتا; Foam cell; Interferon-beta; Macrophage; Animal models; Cardiovascular disease;
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients
Keywords: اینترفرون بتا; MS; multiple sclerosis; IFN-β; interferon beta; NAbs; neutralizing antibodies; MxA; myxovirus resistance A; PCR; polymerase chain reaction; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; EDSS; Expanded Disability Status Scale; EDMUS; European Database
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients
Keywords: اینترفرون بتا; Multiple sclerosis; HLA-DR beta-Chains; Interferon-beta; Frequencies in responders and non-responders; Iran;
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach
Keywords: اینترفرون بتا; AQP4; antibody binds aquaporin 4; CNS; central nervous system; DTI; diffusion tensor images; EDSS; Expanded Disability Status Scale; FDR; false discovery rate; FEW; family-wise error; FA; fractional anisotropy; IFN-β; interferon-beta; MRI; magnetic reson
Plasmacytoid dendritic cell bactericidal activity against Burkholderia pseudomallei
Keywords: اینترفرون بتا; Burkholderia pseudomallei; Melioidosis; Dendritic cells; Interferon-alpha; Interferon-beta;
Suppression of proliferation, tumorigenicity and metastasis of lung cancer cells after their transduction by interferon-beta gene in baculovirus vector
Keywords: اینترفرون بتا; IFN-beta; interferon-beta; BV; baculovirus vector; rBV; recombinant baculovirus vector without interferon-beta gene; rBV/IFN-beta; recombinant baculovirus vector with interferon-beta gene; plaque forming unit; pfu; NCS; newborn calf serum; MOI; multiplici
Cytopathic BVDV-1 strain induces immune marker production in bovine cells through the NF-κB signaling pathway
Keywords: اینترفرون بتا; AP-1; activator protein 1; Bcl3; B-cell leukemia protein 3; BVD; bovine viral diarrhea; BVDV; bovine viral diarrhea virus; cp; cytopathic; DENV; dengue fever virus; EBV; Epstein-Barr virus; hpi; hours post-infection; IFN-β; interferon-beta; IL; interle
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study
Keywords: اینترفرون بتا; Natural killer cells; Multiple sclerosis; Interferon-beta; Natalizumab; NKp46/NCR1 receptor; Peripheral blood mononuclear cells
Socio-economic aspects of the testing for antibodies in MS-patients under interferon therapy in Austria: A cost of illness study
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon-beta; Neutralising antibodies; Cost effectiveness; Markov model;
Pifithrin-α, a pharmacological inhibitor of p53, downregulates lipopolysaccharide-induced nitric oxide production via impairment of the MyD88-independent pathway
Keywords: اینترفرون بتا; Lipopolysaccharide (LPS); Pifithrin-alpha; p53 inhibitor; Nitric oxide; MyD88-independent pathway; Interferon-beta;
DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells
Keywords: اینترفرون بتا; miRNA; microRNA; DDX6; DEAD-box RNA helicase 6; NCR143/145; microRNA-143/145 host non-coding RNA gene; P-bodies; processing bodies; pri-miRNAs; primary microRNA transcripts; pre-miRNAs; microRNA precursors; DDX5; DEAD-box RNA helicase 5; DDX17; DEAD-box R
Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
Keywords: اینترفرون بتا; Disease progression; Interferon-beta; Multiple sclerosis; Observational study; Prognosis
Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models
Keywords: اینترفرون بتا; Therapeutic stem cells; Cytosine deaminase; Interferon-beta; Colorectal cancer; Xenograft model
Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis
Keywords: اینترفرون بتا; Interferon-beta; HERV-H; HERV-W; EBV, HSV, VZV, CMV; Complement activation; Multiple sclerosis;
Long-term adherence to interferon-beta treatment in a cohort of RRMS patients in Belgrade, Serbia
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon-beta; Adherence; Efficacy; Safety; Treatment discontinuation
Analysis of interferon-beta mRNA stability control after poly(I:C) stimulation using RNA metabolic labeling by ethynyluridine
Keywords: اینترفرون بتا; Interferon-beta; Poly(I:C); mRNA transcription; mRNA stability; Ethynyluridine; Metabolic labeling
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells
Keywords: اینترفرون بتا; MS; multiple sclerosis; RRMS; relapsing-remitting MS; IFN-beta; interferon-beta; pDCs; plasmacytoid dendritic cells; DMT; disease-modifying treatment; PBMC; peripheral blood mononuclear cells; TLR9; Toll-like receptor 9; CSF; cerebrospinal fluid; RT-qPC
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review
Keywords: اینترفرون بتا; sarcoidosis; interferon-beta; multiple sclerosis; chronic inflammation
Discontinuación y adherencia a largo plazo en la terapia con interferón beta en pacientes con esclerosis múltiple
Keywords: اینترفرون بتا; Adherencia; Esclerosis múltiple; Interferón-beta; Discontinuación; Cumplimiento; Adherence; Multiple sclerosis; Interferon beta; Discontinuation; Compliance;
IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis
Keywords: اینترفرون بتا; Interferon-beta; Glucocorticoid-induced tumor necrosis factor receptor; Regulatory T cells; Dendritic cells; Multiple sclerosis
Toll-like receptors in chronic pain
Keywords: اینترفرون بتا; TLRs; Toll-like receptors; ERK; extracellular signal-regulated kinase; JNK; c jun N-terminal kinase; IL; interleukin; TNF-α; tumor necrosis factor-α; PGE2; prostaglandin E2; GLT1; glutamate transporter 1; GLAST; glutamate aspartate transporter; LPS; lip
Short communicationOpposite effects of interferon-beta on new B and T cell release from production sites in multiple sclerosis patients
Keywords: اینترفرون بتا; k-deleting recombination excision circles; T-cell receptor excision circles; Multiple sclerosis; Interferon-beta;
IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Polymorphisms; Interferon-beta; Response
Early treatment in multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; CIS; Magnetic resonance imaging; Interferon-beta; Glatiramer acetate; Early treatment
Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential
Keywords: اینترفرون بتا; Measles virus; V protein; MDA5; IRF-3; Interferon-beta;
Research ReportInterferon β-1b directly modulates human neural stem/progenitor cell fate
Keywords: اینترفرون بتا; IFN-β; interferon-beta; MS; multiple sclerosis; CNS; central nervous system; hNPC; human neural stem/progenitor cell; β3-tub; β Tubulin III; BBB; blood brain barrier; Multiple sclerosis; Interferon-beta; Neural progenitor cells;
Review of methodological issues of clinical trials in multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Clinical trial design; Disease-modifying treatments; Interferon-beta; Glatiramer acetate; Surrogate markers; Magnetic resonance imaging
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Natural killer receptors; Interferon-beta; CD56; LILRB1; KIR
Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferon-beta
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon-beta; Plasmacytoid dendritic cells; Chemokines; TLR9; Chemokine receptors; CCR7; CCL3; CCL4; CCL5; CCR5;
Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway
Keywords: اینترفرون بتا; Toll-like receptor 3; TICAM-1 (TRIF); TRAF2; TRAF6; Interferon-beta;
Overlapping and distinct mechanisms of action of multiple sclerosis therapies
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon-beta; Glatiramer acetate; Mitoxantrone; Natalizumab; Combination therapy; Mechanism of action
Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy
Keywords: اینترفرون بتا; Multiple sclerosis; Natural killer receptors; LILRB1; CD56; Interferon-beta;
High productivity of human recombinant beta-interferon from a low-temperature perfusion culture
Keywords: اینترفرون بتا; Interferon-beta; Aggregation; Denaturation; Concentration; Temperature; Residence time; Perfusion; Bioreactor; Batch; Hydrophobic
Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis
Keywords: اینترفرون بتا; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Estrogen; Interferon-beta; Cytokine
Maximising therapeutic outcomes in patients failing on current therapy
Keywords: اینترفرون بتا; Multiple sclerosis; Glatiramer acetate; Interferon-beta; Switching; Treatment failure; Observational studies
Maladie de Crohn au cours d’une sclérose en plaques : rôle de l’interféron bêta
Keywords: اینترفرون بتا; Maladie de Crohn; Interféron bêta; Sclérose en plaques; Effets secondairesCrohn's disease; Interferon-beta; Multiple sclerosis; Adverse effects
Implications of neutralising antibodies on therapeutic efficacy
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon-beta; Neutralising antibodies; Relapse; Monitoring; Guidelines
What can be learned from open direct comparative trials in multiple sclerosis?
Keywords: اینترفرون بتا; Multiple sclerosis; Glatiramer acetate; Interferon-beta; Observational studies; Relapses; Disability
HLA class I and II alleles and response to treatment with interferon-beta in relapsing–remitting multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; HLA class I; HLA class II; Interferon-beta